Kostrzebski, Melissa

Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial

Simuni, T., Fiske, B., Merchant, K., Coffey, C. S., Klingner, E., Caspell-Garcia, C., Lafontant, D.-E., Matthews, H., Wyse, R. K., Brundin, P., et al. (2021) · JAMA Neurology

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 149

Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study

Adams, J. L., Kangarloo, T., Tracey, B., O’Donnell, P., Volfson, D., Latzman, R. D., Zach, N., Alexander, R., Bergethon, P., Cosman, J., et al. (2023) · npj Parkinson's Disease

Parkinson's Disease Mechanisms and TreatmentsContext-Aware Activity Recognition Systems

Cited by 98

Towards interpretable speech biomarkers: exploring MFCCs

Tracey, B., Volfson, D., Glass, J., Haulcy, R., Kostrzebski, M., Adams, J., Kangarloo, T., Brodtmann, A., Dorsey, E. R., & Vogel, A. (2023) · Scientific Reports

Voice and Speech DisordersPhonocardiography and Auscultation Techniques

Cited by 46

Mapping Relevance of Digital Measures to Meaningful Symptoms and Impacts in Early Parkinson’s Disease

Mammen, J. R., Speck, R. M., Stebbins, G. M., Müller, M. L. T. M., Yang, P. T., Campbell, M., Cosman, J., Crawford, J. E., Dam, T., Hellsten, J., et al. (2023) · Journal of Parkinson’s Disease

Parkinson's Disease Mechanisms and TreatmentsHealth Education and Validation

Cited by 38

Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson’s

Mammen, J. R., Lerner, A., Al-Rubayie, R., Kostrzebski, M., Stephenson, D., Xiao, Y., Redmond, C., Tyo, M., Reddy, V. G., Auinger, P., et al. (2025) · Journal of Neurology

Parkinson's Disease Mechanisms and TreatmentsBalance, Gait, and Falls Prevention

Cited by 18